April 27, 2021
Study finds virtual community platform beneficial for engagement in health research
By Jen Schutz
Community engagement is the bridge that connects researchers and local communities; however, face-to-face engagement is often limited in reach and scale — especially during a pandemic. In a recently published paper, researchers from Mayo Clinic and the University of Minnesota evaluated the feasibility of a virtual statewide Facebook community platform to enhance public trust and […]
Tags: Center for Clinical and Translational Science, Center for Health Equity and Community Engagement Research, Christi Patten, community engagement, health sciences research, Tabetha Brockman, University of Minnesota
February 2, 2021
Diabetes treatment disparities widespread, room for improvement
More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]
Tags: Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy, Rozalina McCoy
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
May 18, 2020
Mayo Clinic Research in the News — Week in Review 5/18/2020
Mayo Clinic researchers continue to share both their expertise and their research findings in regional, national and international news. Collected here are links and snippets from some of the stories from around the world. They connect Mayo Clinic research and international efforts to understand and reduce the devastating effects of the SARS-CoV-2 virus and COVID-19. Data […]
Tags: antibacterial resistance, antibodies, artificial intelligence, cardiology, cardiovascular medicine, clinical trials, COVID-19, Gianrico Farrugia, heart failure, infectious disease, Mayo Clinic Health System, Michael Joyner